可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]杨启红,徐强,司良毅. 糖基化终产物对单核细胞源性巨噬细胞过氧化物酶体增殖物激活型受体7表达的影响[J]. 中华老年心脑血管病杂志, 2008, 10(3):214-217.
[2] 尹志勇,魏丽萍,郝媛媛,等. LY333531对高糖所致心肌微血管内皮细胞通透性上调的拮抗作用[J]. 细胞与分子免疫学杂志, 2009, 25(4):303-305.
[3]Staton CA, Stribbling SM, Tazzyman S, et al. Current methods assaying angiogenes is in vitro and in vivo[J]. Int J Exp Pathol, 2004, 85(5):233-248.
[4] Takeuchi M, Yamagishi S. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer’s disease[J]. Curr Pharm Des, 2008, 14(10):973-978.
[5] Huijberts MS, Schaper NC, Schalkwijk CG. Advanced glycation end products and diabetic foot disease[J]. Diabetes Metab Res Rev, 2008, 24(Suppl 1):S19-S24.
[6]Poul MA, Becerril B, Nielsen UB, et al. Selection of tumor-specific internalizing human antibodies from phage libraries[J]. J Mol Biol, 2000, 301(5):1149-1161.
[7]Du Y, Weed SA, Xiong WC, et al. Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons[J]. Mol Cell Biol, 1998, 18(10):5838-5851.
[8]Sabbah HN, Sharov VG. Apoptosis in heart failure[J]. Prog Cardiolvasc Dis, 1998, 40(6):549-562.
[9]Ayalasomayajula SP, Kompella UB. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model[J]. Eur J Pharmaco, 2003, 458 (3):283-289.